Most community protocols wait longer than that - typically 8 weeks of tirzepatide alone before adding cagrilintide
Side Effects and Safety Both AOD 9604 and Semaglutide are generally considered safe, but they have different side effect profiles: AOD 9604 : This peptide has minimal reported side effects in clinical studies, making it a safer option for individuals who are sensitive to traditional growth hormone therapy
It is well tolerated, easy for patients to self-administer, and it keeps mitochondrial support steady through the period when the body is doing the most cellular work
Their combined effects enhance the regeneration of soft tissue and may improve the overall healing process
Many of these new substances appear so fast and with little efficacy support in the literature making it difficult for anti-doping authorities to properly evaluate and consider if they are a problem from the standpoint of performance enhancement
Dosing began at 0.25 mg of each active drug and escalated every four weeks until the full 2.4 mg dose was reached by week 16